the german life sciences trend analysis 2014
DESCRIPTION
The German Life Sciences Trend Analysis 2014. About Us. The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www.biotechgate.com - PowerPoint PPT PresentationTRANSCRIPT
The German Life Sciences Trend Analysis 2014
About Us
The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www.biotechgate.com
The German Biotech Database is a part of the global Biotechgate and is brought to you in partnership with BIO NRW - Cluster Biotechnology North Rhine-Westphalia; representing an active, multicentric network developing into a technological pacesetter for NRW’s life science business. www.germanbiotech.com
Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www.venturevaluation.com
Overview of the German Life-science Industry
2014 Statistics
Total Biotech Companies 884
Medtech companies 497
Pharma companies 69
Investor companies 33
Public / Non-Profit Organizations / Medical Facilities 248
Other Life sciences companies 1082
Percentage of Publicly Owned Companies 2%
Venture Capital Raised (2013) USD 278m
Venture Capital Raised (2012) USD 309m
Number of Technologies 443
Licensing Opportunities 421
Number of Employees
Company Ownership
Overview of the German Biotechnology Industry
2013 Statistics
2014 Statistics
991 Total Biotech Companies 884
162 Biotech - Therapeutics 130
661 Biotech - R&D Services 608
168 Biotech - Other 146
91% Percentage of SME's 95%
2% Percentage of Publicly Owned Companies 2%
USD 305m (2012)
Venture Capital RaisedUSD 210m
(2013)
411 Licensing Opportunities 421
Company Foundation Timeline
Key Activities of Biotechnology Companies
Biotech products - Breakdown by Indication
Products in the Pipeline – Three-year Trend
Venture Biotech Financing in Germany
Major Biotech Financing Rounds (H2 2013 – H1 2014)
Company Sector USD M
Glycotope GmbH Biotechnology - Therapeutics and Diagnostics 76
Ganymed Pharmaceuticals AG
Biotechnology - Therapeutics and Diagnostics 60.7
immatics biotechnologies GmbH
Biotechnology - Therapeutics and Diagnostics 46.4
Isarna Therapeutics GmbH
Biotechnology - Therapeutics and Diagnostics 17.7
Isarna Therapeutics GmbH
Biotechnology - Therapeutics and Diagnostics 7.6
About Biotechgate
Biotechgate contains over 30’000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data.
To register for free or learn more about the different subscription options, please visit www.biotechgate.com.
Terms of Use
The “German Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at www.biotechgate.com. The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof.
The use of the figures and graphs provided in this report is free of charge for any presentations as long as www.biotechgate.com is clearly cited as the source. For all other uses please contact us for terms and conditions.
Biotechgatec/o Venture Valuation VV AGKasernenstrasse 11 +41 (43) 321 86 608004 Zurich [email protected] www.venturevaluation.com